Scorpius Holdings, Inc. (SCPX)

USD 0.29

(-0.87%)

Eps Summary of Scorpius Holdings, Inc.

  • Scorpius Holdings, Inc.'s latest annual eps in 2023 was -347.20 USD , down -2.35% from previous year.
  • Scorpius Holdings, Inc.'s latest quarterly eps in 2024 Q2 was -0.03 USD , up 13.96% from previous quarter.
  • Scorpius Holdings, Inc. reported an annual eps of -339.25 USD in 2022, down -20.57% from previous year.
  • Scorpius Holdings, Inc. reported an annual eps of -281.54 USD in 2021, up 13.5% from previous year.
  • Scorpius Holdings, Inc. reported a quarterly eps of -0.03 USD for 2024 Q2, up 13.96% from previous quarter.
  • Scorpius Holdings, Inc. reported a quarterly eps of -0.53 USD for 2023 Q2, down -8.16% from previous quarter.

Annual Eps Chart of Scorpius Holdings, Inc. (2023 - 2015)

Historical Annual Eps of Scorpius Holdings, Inc. (2023 - 2015)

Year Eps Eps Growth
2023 -347.20 USD -2.35%
2022 -339.25 USD -20.57%
2021 -281.54 USD 13.5%
2020 -325.98 USD -94.05%
2019 -842.04 USD 33.33%
2018 -1259.75 USD 70.77%
2017 -4311.30 USD 56.94%
2016 -9940.00 USD -5461.11%
2015 -35.42 Thousand USD 0.0%

Peer Eps Comparison of Scorpius Holdings, Inc.

Name Eps Eps Difference
AIM ImmunoTech Inc. -0.60 USD -57766.667%
Ampio Pharmaceuticals, Inc. -10.67 USD -3153.983%
Armata Pharmaceuticals, Inc. -1.91 USD -18078.01%
Actinium Pharmaceuticals, Inc. -1.83 USD -18872.678%
Azitra, Inc. -54.76 USD -534.039%
Can-Fite BioPharma Ltd. -1.79 USD -19296.648%
Chromocell Therapeutics Corporation -1.28 USD -27025.0%
Calidi Biotherapeutics, Inc. -1.73 USD -19969.364%
CEL-SCI Corporation -0.73 USD -47461.644%
iBio, Inc. -6.50 USD -5241.538%
Lineage Cell Therapeutics, Inc. -0.12 USD -289233.333%
MAIA Biotechnology, Inc. -1.49 USD -23202.013%
Matinas BioPharma Holdings, Inc. -5.28 USD -6475.758%
Navidea Biopharmaceuticals, Inc. -0.59 USD -58747.458%
NovaBay Pharmaceuticals, Inc. -138.65 USD -150.415%
NanoViricides, Inc. -0.70 USD -49500.0%
Oragenics, Inc. -9.18 USD -3682.135%
BiomX Inc. -5.10 USD -6707.843%
BiomX Inc. -5.10 USD -6707.843%
Protalix BioTherapeutics, Inc. 0.12 USD 289433.333%
Palatin Technologies, Inc. -2.02 USD -17088.119%